Jazz Pharmaceuticals plc — Director's Dealing 2023

Jun 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2023-06-05

Reporting Person: Iannone Robert (EVP, Global Head of Research a)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-05	Ordinary Shares	D	1311	$129.73	Disposed	45315	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.